Filana Therapeutics director Michael O'Donnell to resign after annual meeting
PUBT · 04/28 20:07
Share
Listen to the news
- Filana Therapeutics director Michael O'Donnell plans to resign from board at conclusion of 2026 annual meeting of stockholders.
- O'Donnell will remain on board until resignation takes effect.
- Departure was not tied to any disagreement with Filana, management, or board over operations, policies, or practices.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Filana Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-013638), on April 28, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending